- Rank in Search Criteria: 2891
World Rank (Jan-05-2024): 16,730
World Rank (Jul-30-2023): 16730
Market Cap (Jul-30-2023): 0.26 Billion USD
World Rank (Jan-2022): 17,514
Market Cap (Jan-2022): 0.26 Billion USD
- Rank in Search Criteria: 2892
World Rank (Jan-05-2024): 16,730
Market Cap (Jan-05-2024): 0.25 Billion USD
World Rank (Jul-30-2023): 18047
Market Cap (Jul-30-2023): 0.20 Billion USD
World Rank (Jan-2022): 26,613
Market Cap (Jan-2022): 0.05 Billion USD
- Rank in Search Criteria: 2893
World Rank (Jan-05-2024): 16,731
Market Cap (Jan-05-2024): 0.25 Billion USD
World Rank (Jul-30-2023): 15610
Market Cap (Jul-30-2023): 0.31 Billion USD
World Rank (Jan-2022): 11,516
Market Cap (Jan-2022): 0.69 Billion USDAnnual Revenue in USD: 100 Million USD
Annual Net Income in USD: 19 Million USD
Annual Results for Period ending: Dec-2020 ending yearCompany Profile: Real estate investment company with headquarters is in Paris, France.
- Rank in Search Criteria: 2894
World Rank (Jan-05-2024): 16,732
Market Cap (Jan-05-2024): 0.25 Billion USD
World Rank (Jul-30-2023): 18373
Market Cap (Jul-30-2023): 0.19 Billion USD
World Rank (Jan-2022): 15,830
Market Cap (Jan-2022): 0.35 Billion USD
- Rank in Search Criteria: 2895
World Rank (Jan-05-2024): 16,733
Market Cap (Jan-05-2024): 0.25 Billion USD
World Rank (Jul-30-2023): 12183
Market Cap (Jul-30-2023): 0.55 Billion USD
World Rank (Jan-2022): 8,157
Market Cap (Jan-2022): 1.28 Billion USDAnnual Revenue in USD: 179 Million USD
Annual Operating Income in USD: -66 Million USD
Annual Net Income in USD: -50 Million USD
Annual Results for Period ending: Dec-2022 ending yearCompany Profile: Oxford Biomedica is a Pioneer of gene and cell therapy with a position in Lentiviral Vector Research, Development and Bioprocessing company. It have created a valuable portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders and provide with multiple income streams, consisting of upfront milestone payments, development and production fees and potential royalties on future product sales. The headquarters is in UK.
- Rank in Search Criteria: 2896
World Rank (Jan-05-2024): 16,735
World Rank (Jul-30-2023): 16735
World Rank (Jan-2022): 16,735
Market Cap (Jan-2022): 0.30 Billion USDHeadquarters Country: Italy
- Rank in Search Criteria: 2897
World Rank (Jan-05-2024): 16,735
Market Cap (Jan-05-2024): 0.25 Billion USD
World Rank (Jul-30-2023): 16150
Market Cap (Jul-30-2023): 0.29 Billion USD
World Rank (Jan-2022): 16,856
Market Cap (Jan-2022): 0.29 Billion USDCompany Profile: SEVERFIELD PLC is steel industries and metal fabrication industries company. The company annual revenue is 363.2 million EUR, annual operating income is 22.6 million EUR and total assets are 337.7 million EUR as of 2021. The headquarters is in UK.
As on 2021, with multiple sites in the UK and its India factory, they had an annual capacity to produce around 300,000 tons of fabricated steelwork.
As on 2021, they have 5 manufacturing facilities across the UK and one in India.
- Rank in Search Criteria: 2898
World Rank (Jan-05-2024): 16,736
Market Cap (Jan-05-2024): 0.25 Billion USD
World Rank (Jul-30-2023): 16483
Market Cap (Jul-30-2023): 0.27 Billion USD
World Rank (Jan-2022): 21,539
Market Cap (Jan-2022): 0.13 Billion USDHeadquarters Country: Italy
- Rank in Search Criteria: 2899
World Rank (Jan-05-2024): 16,738
Market Cap (Jan-05-2024): 0.25 Billion USD
World Rank (Jul-30-2023): 16331
Market Cap (Jul-30-2023): 0.28 Billion USD
World Rank (Jan-2022): 16,697
Market Cap (Jan-2022): 0.30 Billion USD
- Rank in Search Criteria: 2900
World Rank (Jan-05-2024): 16,752
World Rank (Jul-30-2023): 16752
World Rank (Jan-2022): 16,752
Market Cap (Jan-2022): 0.30 Billion USD